Developer docs
API playgroundTry for free, no card

Search company profiles

Medaffcon

Full company profile

uuid000zaw8

Namestring
Medaffcon
Legal namestring
Medaffcon Oy
Websiteurl
medaffcon.fi
Company typeenum
Private
Founded yearint
2009
Descriptiontext

Medaffcon is a Nordic pharmaceutical and healthcare consulting firm headquartered in Espoo, Finland, with a regional office in Stockholm, Sweden (Medaffcon AB). The company is a wholly-owned subsidiary of Tamro, a Finnish pharmaceutical wholesale and healthcare logistics provider, and operates with shared executive leadership with the parent. Founded around 2009-2010, Medaffcon delivers four integrated practice lines: Real World Evidence (RWE) generation across the product lifecycle, Market Access strategy and reimbursement support across Nordic markets, Medical Affairs services including medical communication and advisory boards, and Expert Resourcing placing senior consultants into client organisations.

The company's technology stack applies modern data solutions to health economic and clinical work, including OMOP Common Data Model-based data harmonisation, synthetic data and digital twins for drug development support, and machine learning and AI-based solutions for analytics. Service delivery is powered by a small bench of highly credentialed staff (PhDs, MScs) supported by an external expert network spanning pharma, healthcare, academia, and the OHDSI research community.

Medaffcon's commercial model is professional services: project-based, quote-based engagements priced against client needs, reached via direct expert-to-expert sales through business development managers. Pricing is not publicly disclosed. The primary customer segments are pharmaceutical companies requiring evidence generation, market entry strategy, and reimbursement support, with healthcare organisations and academic/research institutions as adjacent segments. Geographic focus is explicitly Nordic (Finland and Sweden), with no claimed global footprint.

Short descriptiontext

Medaffcon is a Nordic pharmaceutical and healthcare consulting firm providing Real World Evidence, Market Access, Medical Affairs, and Expert Resourcing services to pharmaceutical companies across Finland and Sweden, operating as a subsidiary of Tamro.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersEspoo, Finland
HQ citystring
Espoo
HQ countrystring
Finland
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
real world evidence, market access consulting, medical affairs services, health economics research, pharmaceutical consulting
Industry2 codes
PRIMARYHLAGAOAN
Market Access, Pricing & Reimbursement (Evidence Generation) FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAG
Medical Affairs, Scientific Communications & HEOR FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
NAICS code3 codes
  • Scientific Research and Development Services5417
  • Management Consulting Services54161
  • Other Scientific and Technical Consulting Services541690
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Management Consulting Services8742
Product category
Pharmaceutical Consulting
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Professional Consulting Services
TypeProfessional Services
Description

Medaffcon generates revenue through providing expert consulting services in Real World Evidence, Market Access, and Medical Affairs. Services are delivered by highly qualified experts (PhDs, MSc holders) and include project-based consulting, study execution, and strategic advisory engagements.

medaffcon.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Medaffcon provides tailored research and expert consulting services to the pharmaceutical industry and healthcare sector across the Nordics. The company delivers four interconnected service lines — Real World Evidence (RWE) generation, Market Access strategy and modeling, Medical Affairs support, and Expert Resourcing — that span the pharmaceutical product lifecycle from evidence generation and market entry to medical communications and interim expert staffing.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Medaffcon is a Nordic consulting and research organization offering a portfolio of four interconnected expert services: Real World Evidence (RWE), Market Access, Medical Affairs, and Expert Resourcing. These services are designed to work together across the pharmaceutical product lifecycle — from evidence generation and market entry strategy to medical communications and expert staffing — supporting pharmaceutical and healthcare actors in the Nordic markets. The company combines medical and health economic perspectives with data solutions, leveraging a cooperative network spanning the pharmaceutical industry, healthcare, academia, and the research community.

Product and service4 records
1Real World Evidence (RWE)
CategoryEvidence Generation / Real World Evidence
Description

Tailored evidence generation across the pharmaceutical product lifecycle — from gap analysis and strategy workshops to full study execution, fast-track data requests, interactive tools, and payer-ready evidence packages. Targeted at pharmaceutical and healthcare organizations needing RWE studies to support knowledge-based decision making.

2Market Access
CategoryMarket Access / Reimbursement Consulting
Description

Support for all phases of market entry and life-cycle management — from strategy and modeling to reimbursement submissions, risk sharing, interactive decision tools, and market analytics across Nordic markets. Targeted at pharmaceutical companies commercializing or managing products across the Nordics.

3Medical Affairs
CategoryMedical Affairs / Medical Communications
Description

Flexible support in medical communication, literature synthesis, advisory boards, stakeholder mapping, medical training, healthcare environment assessments, and expert interim staffing to strengthen clients' medical strategy. Targeted at pharmaceutical companies and healthcare organizations with medical affairs functions.

4Expert Resourcing
CategoryExpert Resourcing / Interim Staffing
Description

Provides client access to a network of healthcare, pharmaceutical, and research experts for consulting assignments and interim staffing needs. Targeted at pharmaceutical and healthcare organizations needing specialized expert support on a flexible basis.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Tamro is a pharmaceutical wholesale and healthcare logistics company that serves as Medaffcon's parent company. Heikki Koski, CEO of Medaffcon Group, continues to serve as a member of Tamro's executive team. He previously served as Director of Service Business and Development at Tamro and was a board member of Medaffcon since 2020. Medaffcon operates as a subsidiary of Tamro with shared executive leadership.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Regulatory, market access, and pharmacovigilance consulting firm to pharma. Comparable to Medaffcon on Market Access and reimbursement submissions across European markets.

TypeBroad incumbent
Description

Global leader in clinical, real-world evidence, HEOR, and market access services to pharma. Medaffcon competes on the same RWE/Market Access deliverables but with a Nordic specialization versus IQVIA's global scale.

TypeBroad incumbent
Description

Global biopharmaceutical solutions organization including clinical, commercial, and RWE services. Overlaps with Medaffcon on RWE and commercial/market access.

4Lattice Group
TypeEmerging player
Description

Specialist HEOR and market access consulting firm focused on payer evidence generation. Comparable to Medaffcon on HEOR-focused services and payer evidence work.

TypeDirect peer
Description

European mid-sized CRO with Nordic presence and full clinical/market access services. Comparable to Medaffcon on pharma services and Nordic coverage.

TypeBroad incumbent
Description

Global CRO and healthcare intelligence firm with RWE, HEOR, and market access capabilities. Comparable to Medaffcon on RWE and Market Access offerings but vastly larger scale and geographic reach.

TypeDirect peer
Description

Specialist HEOR, RWE, and market access consulting firm, now part of PPD/Thermo Fisher. Direct peer to Medaffcon's HEOR/RWE/Market Access core, with similar service portfolio.

TypeDirect peer
Description

Finnish CRO offering clinical and regulatory services to pharma. Direct Nordic peer to Medaffcon, with overlapping pharma services and Finnish footprint.

TypeDirect peer
Description

Statistical and data-analytics focused CRO with strong RWE and biostatistics offerings. Comparable to Medaffcon on data-driven RWE study execution.

TypeBroad incumbent
Description

Global CRO with commercial launch, market access, and real-world evidence services. Overlaps with Medaffcon on Market Access and RWE work for pharma clients.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Medaffcon

Pharmaceutical Consultingmedaffcon.fi

Medaffcon is a Nordic pharmaceutical and healthcare consulting firm providing Real World Evidence, Market Access, Medical Affairs, and Expert Resourcing services to pharmaceutical companies across Finland and Sweden, operating as a subsidiary of Tamro.

What Medaffcon does

Medaffcon is a Nordic pharmaceutical and healthcare consulting firm headquartered in Espoo, Finland, with a regional office in Stockholm, Sweden (Medaffcon AB). The company is a wholly-owned subsidiary of Tamro, a Finnish pharmaceutical wholesale and healthcare logistics provider, and operates with shared executive leadership with the parent. Founded around 2009-2010, Medaffcon delivers four integrated practice lines: Real World Evidence (RWE) generation across the product lifecycle, Market Access strategy and reimbursement support across Nordic markets, Medical Affairs services including medical communication and advisory boards, and Expert Resourcing placing senior consultants into client organisations.

The company's technology stack applies modern data solutions to health economic and clinical work, including OMOP Common Data Model-based data harmonisation, synthetic data and digital twins for drug development support, and machine learning and AI-based solutions for analytics. Service delivery is powered by a small bench of highly credentialed staff (PhDs, MScs) supported by an external expert network spanning pharma, healthcare, academia, and the OHDSI research community.

Medaffcon's commercial model is professional services: project-based, quote-based engagements priced against client needs, reached via direct expert-to-expert sales through business development managers. Pricing is not publicly disclosed. The primary customer segments are pharmaceutical companies requiring evidence generation, market entry strategy, and reimbursement support, with healthcare organisations and academic/research institutions as adjacent segments. Geographic focus is explicitly Nordic (Finland and Sweden), with no claimed global footprint.

Medaffcon firmographics

Firmographics
Name
Medaffcon
Legal name
Medaffcon Oy
Website
https://medaffcon.fi
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
11–50 employees
Short description
Medaffcon is a Nordic pharmaceutical and healthcare consulting firm providing Real World Evidence, Market Access, Medical Affairs, and Expert Resourcing services to pharmaceutical companies across Finland and Sweden, operating as a subsidiary of Tamro.
Ownership category
akta.pro rank

Medaffcon industry classification

Industry
Product category
Pharmaceutical Consulting
NAICS
Scientific Research and Development Services (5417), Management Consulting Services (54161), Other Scientific and Technical Consulting Services (541690)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYHLAGAOAN
Market Access, Pricing & Reimbursement (Evidence Generation) FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAG
Medical Affairs, Scientific Communications & HEOR FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

Keywords

  • Real world evidence
  • Market access consulting
  • Medical affairs services
  • Health economics research
  • Pharmaceutical consulting

Where Medaffcon is headquartered

Location

Headquarters

HQ city
Espoo
HQ country
Finland
HQ region
Europe

Offices2 records

Markets served

Medaffcon business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Professional Consulting Services: Medaffcon generates revenue through providing expert consulting services in Real World Evidence, Market Access, and Medical Affairs. Services are delivered by highly qualified experts (PhDs, MSc holders) and include project-based consulting, study execution, and strategic advisory engagements.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Medaffcon product offering

Product offering

Core offering

Medaffcon provides tailored research and expert consulting services to the pharmaceutical industry and healthcare sector across the Nordics. The company delivers four interconnected service lines — Real World Evidence (RWE) generation, Market Access strategy and modeling, Medical Affairs support, and Expert Resourcing — that span the pharmaceutical product lifecycle from evidence generation and market entry to medical communications and interim expert staffing.

Product overview

Medaffcon is a Nordic consulting and research organization offering a portfolio of four interconnected expert services: Real World Evidence (RWE), Market Access, Medical Affairs, and Expert Resourcing. These services are designed to work together across the pharmaceutical product lifecycle — from evidence generation and market entry strategy to medical communications and expert staffing — supporting pharmaceutical and healthcare actors in the Nordic markets. The company combines medical and health economic perspectives with data solutions, leveraging a cooperative network spanning the pharmaceutical industry, healthcare, academia, and the research community.

Differentiator

Problem solved

Functional benefit

Products and services

  • Real World Evidence (RWE) Tailored evidence generation across the pharmaceutical product lifecycle — from gap analysis and strategy workshops to full study execution, fast-track data requests, interactive tools, and payer-ready evidence packages. Targeted at pharmaceutical and healthcare organizations needing RWE studies to support knowledge-based decision making.
  • Market Access Support for all phases of market entry and life-cycle management — from strategy and modeling to reimbursement submissions, risk sharing, interactive decision tools, and market analytics across Nordic markets. Targeted at pharmaceutical companies commercializing or managing products across the Nordics.
  • Medical Affairs Flexible support in medical communication, literature synthesis, advisory boards, stakeholder mapping, medical training, healthcare environment assessments, and expert interim staffing to strengthen clients' medical strategy. Targeted at pharmaceutical companies and healthcare organizations with medical affairs functions.
  • Expert Resourcing Provides client access to a network of healthcare, pharmaceutical, and research experts for consulting assignments and interim staffing needs. Targeted at pharmaceutical and healthcare organizations needing specialized expert support on a flexible basis.

Companies that use Medaffcon

Customer profile

Segments3 records

Ideal customer profiles2 records

Medaffcon technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Medaffcon partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • TamrocoreStrategic or Co-development PartnerTamro is a pharmaceutical wholesale and healthcare logistics company that serves as Medaffcon's parent company. Heikki Koski, CEO of Medaffcon Group, continues to serve as a member of Tamro's executive team. He previously served as Director of Service Business and Development at Tamro and was a board member of Medaffcon since 2020. Medaffcon operates as a subsidiary of Tamro with shared executive leadership.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Medaffcon competitors and assessment

Company assessment

Direct peers

  • PharmaLex: Regulatory, market access, and pharmacovigilance consulting firm to pharma. Comparable to Medaffcon on Market Access and reimbursement submissions across European markets.
  • TFS HealthScience: European mid-sized CRO with Nordic presence and full clinical/market access services. Comparable to Medaffcon on pharma services and Nordic coverage.
  • Evidera (PPD / Thermo Fisher): Specialist HEOR, RWE, and market access consulting firm, now part of PPD/Thermo Fisher. Direct peer to Medaffcon's HEOR/RWE/Market Access core, with similar service portfolio.
  • Medfiles: Finnish CRO offering clinical and regulatory services to pharma. Direct Nordic peer to Medaffcon, with overlapping pharma services and Finnish footprint.
  • Cytel: Statistical and data-analytics focused CRO with strong RWE and biostatistics offerings. Comparable to Medaffcon on data-driven RWE study execution.

Broad incumbents

  • IQVIA: Global leader in clinical, real-world evidence, HEOR, and market access services to pharma. Medaffcon competes on the same RWE/Market Access deliverables but with a Nordic specialization versus IQVIA's global scale.
  • Syneos Health: Global biopharmaceutical solutions organization including clinical, commercial, and RWE services. Overlaps with Medaffcon on RWE and commercial/market access.
  • ICON plc: Global CRO and healthcare intelligence firm with RWE, HEOR, and market access capabilities. Comparable to Medaffcon on RWE and Market Access offerings but vastly larger scale and geographic reach.
  • Parexel International: Global CRO with commercial launch, market access, and real-world evidence services. Overlaps with Medaffcon on Market Access and RWE work for pharma clients.

Emerging players

  • Lattice Group: Specialist HEOR and market access consulting firm focused on payer evidence generation. Comparable to Medaffcon on HEOR-focused services and payer evidence work.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Medaffcon social profiles

Digital presence

Medaffcon financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Medaffcon leadership team

Management profile

Number of profiles

Profiles7 records

Medaffcon subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Medaffcon funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Medaffcon M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medaffcon

What does Medaffcon do?

Medaffcon provides tailored research and expert consulting services to the pharmaceutical industry and healthcare sector across the Nordics. The company delivers four interconnected service lines — Real World Evidence (RWE) generation, Market Access strategy and modeling, Medical Affairs support, and Expert Resourcing — that span the pharmaceutical product lifecycle from evidence generation and market entry to medical communications and interim expert staffing.

Is Medaffcon a public or private company?

Medaffcon is a private company. It is classified as corporate owned and is currently operating.

When was Medaffcon founded?

Medaffcon was founded in 2009. It employs 11 to 50 people.

Where is Medaffcon based?

Medaffcon is headquartered in Espoo, Finland, in the Europe region.

How does Medaffcon make money?

One revenue line is on record: professional Consulting Services.

Who are Medaffcon's main competitors?

Direct peers on record are PharmaLex, TFS HealthScience, Evidera (PPD / Thermo Fisher), Medfiles and Cytel. Broad incumbents are IQVIA, Syneos Health, ICON plc and Parexel International. Lattice Group is listed as an emerging player.

Does Medaffcon have an API?

No public API is recorded for Medaffcon.

What industry is Medaffcon in?

Medaffcon's product category is Pharmaceutical Consulting. Its primary akta.pro industry code is HLAGAOAN, Market Access, Pricing & Reimbursement (Evidence Generation) FSP, with a secondary code of HLAGAOAG, Medical Affairs, Scientific Communications & HEOR FSP. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales